Tepha

About:

Tepha is a medical device firm developing and commercializing a new class of absorbable biomaterials to be used in surgical procedures.

Website: http://www.tepha.com

Top Investors: Yield10 Bioscience, Novartis Venture Fund, Armentum Partners, The Vertical Group, Integra Ventures

Description:

Tepha is a medical device firm pursuing the development and commercialization of innovative products based on the company's proprietary biomaterial technology. The technology provides a new class of absorbable biomaterials, known as polyhydroxyalkanoates , which may be tailored to meet unmet needs for medical devices in multiple fields. Tepha's novel, biosynthetically produced materials offer superior performance in flexibility, elasticity, and biocompatibility; and, for its fiber-based products, excellent tensile strength and strength retention.

Total Funding Amount:

$60.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

1998-01-01

Contact Email:

contact(AT)tepha.com

Founders:

Anthony J. Sinskey

Number of Employees:

51-100

Last Funding Date:

2020-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai